CLL monocytes show enhanced PD-1 expression compared to healthy donors, and ligation with recombinant PD-L1 diminishes monocytes switch to aerobic glycolysis, while anti-PD-L1 blockade reverts this effect, promoting phagocytosis of tumor cells (215). The gene discussed is CD274; the disease is B-cell chronic lymphocytic leukemia.